[{"address1": "1055 Westlakes Drive", "address2": "Suite 300", "city": "Berwyn", "state": "PA", "zip": "19312", "country": "United States", "phone": "610 727 3913", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 72, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": 965600, "exercisedValue": 0, "unexercisedValue": 3749000}, {"maxAge": 1, "name": "Mr. Henry  Hagopian III, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 510049, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.8, "open": 8.91, "dayLow": 8.82, "dayHigh": 9.245, "regularMarketPreviousClose": 8.8, "regularMarketOpen": 8.91, "regularMarketDayLow": 8.82, "regularMarketDayHigh": 9.245, "beta": 1.55, "forwardPE": -2.8935485, "volume": 68485, "regularMarketVolume": 68485, "averageVolume": 299600, "averageVolume10days": 200050, "averageDailyVolume10Day": 200050, "bid": 8.91, "ask": 8.97, "bidSize": 1000, "askSize": 900, "marketCap": 94901704, "fiftyTwoWeekLow": 5.42, "fiftyTwoWeekHigh": 23.89, "fiftyDayAverage": 11.5574, "twoHundredDayAverage": 11.17285, "currency": "USD", "enterpriseValue": 85697648, "floatShares": 7479966, "sharesOutstanding": 10579900, "sharesShort": 1367929, "sharesShortPriorMonth": 980189, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.1293, "heldPercentInsiders": 0.26388, "heldPercentInstitutions": 0.123409994, "shortRatio": 5.18, "shortPercentOfFloat": 0.1728, "bookValue": 0.739, "priceToBook": 12.138024, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -41717088, "trailingEps": -4.84, "forwardEps": -3.1, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ANVS", "underlyingSymbol": "ANVS", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "firstTradeDateEpochUtc": 1580308200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e153bc75-9830-375d-bf5e-330db4df878a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.97, "targetHighPrice": 72.0, "targetLowPrice": 9.0, "targetMeanPrice": 34.6, "targetMedianPrice": 30.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 6354942, "totalCashPerShare": 0.619, "quickRatio": 1.783, "currentRatio": 2.868, "returnOnAssets": -1.24072, "returnOnEquity": -2.27846, "freeCashflow": -23621660, "operatingCashflow": -34211728, "financialCurrency": "USD", "trailingPegRatio": null}]